LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 10 of 15: Cell count and normalized growth rate inhibition values within biological replicate 3. - Dataset (ID:20247)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 2 | D09 | 72 | hr | 962 | 1514 | 10507 | 0.1441 | 0.1405 |
MCF 10A | Barasertib | 1.11 | uM | LJP5 | 3 | D09 | 72 | hr | 962 | 1437 | 10315 | 0.1393 | 0.1244 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 1 | D08 | 72 | hr | 962 | 1543 | 10714 | 0.1440 | 0.1455 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 2 | D08 | 72 | hr | 962 | 1426 | 10507 | 0.1357 | 0.1208 |
MCF 10A | Barasertib | 3.33 | uM | LJP5 | 3 | D08 | 72 | hr | 962 | 1513 | 10315 | 0.1467 | 0.1414 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 1 | D07 | 72 | hr | 962 | 1598 | 10714 | 0.1492 | 0.1571 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 2 | D07 | 72 | hr | 962 | 1227 | 10507 | 0.1168 | 0.0730 |
MCF 10A | Barasertib | 10 | uM | LJP5 | 3 | D07 | 72 | hr | 962 | 1571 | 10315 | 0.1523 | 0.1540 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 1 | C18 | 72 | hr | 962 | 10751 | 10714 | 1.0035 | 1.0020 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 2 | C18 | 72 | hr | 962 | 10168 | 10507 | 0.9677 | 0.9810 |
MCF 10A | Vemurafenib | 0.04 | uM | LJP5 | 3 | C18 | 72 | hr | 962 | 10278 | 10315 | 0.9964 | 0.9979 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 1 | C17 | 72 | hr | 962 | 10271 | 10714 | 0.9587 | 0.9759 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 2 | C17 | 72 | hr | 962 | 10387 | 10507 | 0.9885 | 0.9933 |
MCF 10A | Vemurafenib | 0.12 | uM | LJP5 | 3 | C17 | 72 | hr | 962 | 10057 | 10315 | 0.9750 | 0.9852 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 1 | C16 | 72 | hr | 962 | 10663 | 10714 | 0.9952 | 0.9973 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 2 | C16 | 72 | hr | 962 | 10191 | 10507 | 0.9699 | 0.9823 |
MCF 10A | Vemurafenib | 0.37 | uM | LJP5 | 3 | C16 | 72 | hr | 962 | 10075 | 10315 | 0.9767 | 0.9863 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 1 | C15 | 72 | hr | 962 | 10363 | 10714 | 0.9672 | 0.9809 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 2 | C15 | 72 | hr | 962 | 10240 | 10507 | 0.9745 | 0.9851 |
MCF 10A | Vemurafenib | 1.11 | uM | LJP5 | 3 | C15 | 72 | hr | 962 | 9723 | 10315 | 0.9426 | 0.9657 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 1 | C14 | 72 | hr | 962 | 8949 | 10714 | 0.8353 | 0.8991 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 2 | C14 | 72 | hr | 962 | 8336 | 10507 | 0.7933 | 0.8701 |
MCF 10A | Vemurafenib | 3.33 | uM | LJP5 | 3 | C14 | 72 | hr | 962 | 8922 | 10315 | 0.8649 | 0.9170 |
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 1 | C13 | 72 | hr | 962 | 4279 | 10714 | 0.3994 | 0.5360 |
MCF 10A | Vemurafenib | 10 | uM | LJP5 | 2 | C13 | 72 | hr | 962 | 4469 | 10507 | 0.4253 | 0.5609 |